Status:

COMPLETED

Effects of L-citrulline Supplementation on Vascular Function in Metabolic Syndrome

Lead Sponsor:

Texas Tech University

Conditions:

Metabolic Syndrome

Menopause

Eligibility:

FEMALE

45-79 years

Phase:

NA

Brief Summary

The objective of this project is to provide evidence that L-Citrulline (CIT) supplementation can improve vascular function in the fasted and acute hyperglycemia conditions in middle-aged and older wom...

Detailed Description

Using a double-blind, randomized, placebo-controlled, and parallel design, middle-aged and older women with metabolic syndrome will be randomized into receiving either CIT supplementation (10g/day) or...

Eligibility Criteria

Inclusion

  • Must present at least 3 of the following 5 cardiometabolic risk factors
  • Waist circumference ≥88 cm
  • Fasting glucose between 100-125 mg/dL or HbA1c between 5.7-6.4%.
  • Blood pressure ≥130 mm Hg
  • Triglyceride ≥ 150 mg/dL
  • HDL \<50 mg/dL
  • The following are also inclusion criteria's:
  • Women aged 45-79 years old
  • Body mass index ≤ 39.9 kg/m2
  • Sedentary (defined as \< 120 min/week of exercise)
  • Abstain from any dietary supplements with vascular effects for one month prior to the beginning of the study and until participation in study has terminated.

Exclusion

  • \< 45 and \> 79 years of age
  • Use of medications and/or any supplements that may affect outcome variables (such as arginine-containing supplements, nitroglycerin, statin drugs, biguanides, insulin, beta blockers, statins, verapamil)
  • Systolic blood pressure ≥ 160 mmHg
  • BMI \> 40 kg/m2
  • Recent changes in medication (3 months)
  • Current smoking any tobacco use
  • Cardiovascular disease, diabetes (Type 1 or 2), and other metabolic or chronic diseases
  • More than 7 alcoholic drinks/week of consumption

Key Trial Info

Start Date :

January 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2024

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT06025357

Start Date

January 1 2023

End Date

August 1 2024

Last Update

May 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

TTU Kinesiology and Sport Management Building

Lubbock, Texas, United States, 79409